Accéder au contenu
Merck
Toutes les photos(3)

Documents

81323

Sigma-Aldrich

Poly(ethylene glycol) methyl ether

average MN 5,000, methoxy, hydroxyl

Synonyme(s) :

Polyethylene glycol monomethyl ether

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Toutes les photos(3)

About This Item

Formule linéaire :
CH3(OCH2CH2)nOH
Numéro CAS:
9004-74-4
Numéro MDL:
MFCD00084416
Code UNSPSC :
12162002
ID de substance PubChem :
24887753
Nomenclature NACRES :
NA.23

product name

Poly(ethylene glycol) methyl ether, average Mn 5,000

Densité de vapeur

>1 (vs air)

Niveau de qualité

200

Pression de vapeur

0.05 mmHg ( 20 °C)

Forme

flakes
powder or crystals

Poids mol.

average Mn 5,000

Pf

60-64 °C

Extrémité Ω

hydroxyl

Extrémité α

methoxy

InChI

1S/C3H8O2/c1-5-3-2-4/h4H,2-3H2,1H3

Clé InChI

XNWFRZJHXBZDAG-UHFFFAOYSA-N

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Catégories apparentées

Application

Poly(ethylene glycol) methyl ether (mPEG) is a hydrophilic polymer that is used to control the flexibility of a composite. mPEG can be used for a variety of applications such as drug delivery, tissue engineering, and other biological uses.

Autres remarques

Polymer used in the polymer-supported liquid synthesis of oligosaccharides

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

911593

NanoFabTx™ microfluidic - nano, device kit for synthesis of 100-200 nm nanoparticles and liposomes

911860

NanoFabTx™ microfluidic - micro, device kit for synthesis of 1-5 μm particles

911879

NanoFabTx™ microfluidic - micro, device kit for synthesis of 10-30 μm particles

909637

NanoFabTx™ PLGA-nano, for synthesis of 100 and 200 nm particles

912212

NanoFabTx™ PLGA-micro, for synthesis of 10-30 um particles

912220

NanoFabTx™ PLGA-micro, for synthesis of 1-5 μm particles

920436

NanoFabTx™ PEG-PLA drug formulation screening kit, for synthesis of PEGylated nanoparticles

915408

NanoFabTx™ PEGylated nanoparticle formulation screening kit

917796

NanoFabTx™ PEG-PLGA drug formulation screening kit, for synthesis of PEGylated nanoparticles

918881

NanoFabTx™ PEG-PCL drug formulation screening kit, for synthesis of PEGylated nanoparticles

918075

NanoFabTx™ PLA-nano, for synthesis of 100 and 200 nm particles

Code de la classe de stockage

10 - Combustible liquids

Classe de danger pour l'eau (WGK)

WGK 1

Point d'éclair (°F)

359.6 °F - closed cup

Point d'éclair (°C)

182 °C - closed cup

Équipement de protection individuelle

Eyeshields, Gloves

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Hamed Nosrati et al.
Pharmaceutical development and technology, 24(1), 89-98 (2018-01-09)
In this study, we designed a polymersome system for the controlled release of methotrexate (MTX) as an anticancer drug with the objective of improving the loading efficiency of the drug in polymersomes as well as achievement of an efficient control
Yvonne K Girard et al.
PloS one, 8(10), e75345-e75345 (2013-10-23)
The development of a suitable three dimensional (3D) culture system for anticancer drug development remains an unmet need. Despite progress, a simple, rapid, scalable and inexpensive 3D-tumor model that recapitulates in vivo tumorigenesis is lacking. Herein, we report on the
Kangan Li et al.
International journal of nanomedicine, 8, 2589-2600 (2013-07-28)
Development of dual-mode or multi-mode imaging contrast agents is important for accurate and self-confirmatory diagnosis of cancer. We report a new multifunctional, dendrimer-based gold nanoparticle (AuNP) as a dual-modality contrast agent for magnetic resonance (MR)/computed tomography (CT) imaging of breast
Magnetite nanoparticles stabilized with polymeric bilayer of poly (ethylene glycol) methyl ether-poly (?-caprolactone) copolymers
Meerod S, et al.
Polymer, 49(18), 3950-3956 (2008)
S.P. Douglas et al.
Journal of the American Chemical Society, 113, 5095-5095 (1991)
Afficher tous les articles scientifiques apparentés

Articles

Fouling Resistant PEG Based Grafted Polymer Coatings

Biofouling control essential for device performance and safety; minimize accumulation of biomolecules and bioorganisms.

Fouling Resistant PEG Based Grafted Polymer Coatings

Biofouling control essential for device performance and safety; minimize accumulation of biomolecules and bioorganisms.

Fouling Resistant PEG Based Grafted Polymer Coatings

Biofouling control essential for device performance and safety; minimize accumulation of biomolecules and bioorganisms.

Fouling Resistant PEG Based Grafted Polymer Coatings

Biofouling control essential for device performance and safety; minimize accumulation of biomolecules and bioorganisms.

Afficher tout

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique